Literature DB >> 30536993

Independent and joint associations of blood lipids and lipoproteins with lung cancer risk in Chinese males: A prospective cohort study.

Zhangyan Lyu1, Ni Li1, Gang Wang2, Xiaoshuang Feng1, Shuohua Chen3, Kai Su4, Fang Li4, Luopei Wei1, Xin Li1, Shuanghua Xie1, Lanwei Guo1,5, Yuheng Chen1, Fengwei Tan4, Jian Yin1, Hong Cui1, Hongda Chen1, Jiang Li1, Jiansong Ren1, Jufang Shi1, Shouling Wu3, Min Dai1, Jie He4.   

Abstract

To investigate the independent and joint associations of blood lipids and lipoproteins with lung cancer risk in Chinese males, a prospective cohort study was conducted. A total of 109,798 males with baseline information on total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and non-HDL were prospectively observed from 2006 to 2015 for cancer incidence. Cox proportional hazards models and restricted cubic spline (RCS) analysis were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). During a 9-year follow-up, a total of 986 lung cancer cases were identified. Multivariable analyses showed that both males with low TC (HRQ1vs.Q2 = 1.27, 95%CI: 1.02-1.60) and males with high TC (HRQ5vs.Q2 = 1.30, 95%CI: 1.04-1.63) had an increased lung cancer risk, and the U-shaped association was also revealed in the RCS analysis (poverall = 0.013, pnonlinear = 0.006). Furthermore, both low TG (HRQ1vs.Q2 = 1.24, 95%CI: 0.99-1.54) and high TG (HRQ5vs.Q2 = 1.27, 95%CI: 1.01-1.59) were associated with increased lung cancer risk, while low LDL-C (HRQ1vs.Q2 = 1.38, 95%CI: 1.11-1.72) was associated with increased lung cancer risk. When TC, TG and LDL-C were considered jointly, the number of abnormal indicators was linearly associated with an increased risk of lung cancer (ptrend < 0.001), as subjects with three abnormal indicators had a twofold higher risk of developing lung cancer (HR = 2.02, 95%CI: 1.62-2.54). Notably, these associations were statistically significant among never smokers, never drinkers and overweight/obese males. These findings suggest that dyslipidemia may potentially be a modifiable risk factor that has key scientific and clinical significance for lung cancer prevention.
© 2018 UICC.

Entities:  

Keywords:  Chinese males; blood lipids; joint associations; lung cancer; prospective cohort

Mesh:

Substances:

Year:  2019        PMID: 30536993     DOI: 10.1002/ijc.32051

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Clinical Significance of Preoperative Naples Prognostic Score in Patients With Non-Small Cell Lung Cancer.

Authors:  Dahu Ren; Wenbo Wu; Qingtao Zhao; Xiaopeng Zhang; Guochen Duan
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

2.  Risk prediction model for lung cancer incorporating metabolic markers: Development and internal validation in a Chinese population.

Authors:  Zhangyan Lyu; Ni Li; Shuohua Chen; Gang Wang; Fengwei Tan; Xiaoshuang Feng; Xin Li; Yan Wen; Zhuoyu Yang; Yalong Wang; Jiang Li; Hongda Chen; Chunqing Lin; Jiansong Ren; Jufang Shi; Shouling Wu; Min Dai; Jie He
Journal:  Cancer Med       Date:  2020-04-06       Impact factor: 4.452

3.  Development of a risk score for colorectal cancer in Chinese males: A prospective cohort study.

Authors:  Lanwei Guo; Hongda Chen; Gang Wang; Zhangyan Lyu; Xiaoshuang Feng; Luopei Wei; Xin Li; Yan Wen; Ming Lu; Yuheng Chen; Jufang Shi; Jiansong Ren; Chunqing Lin; Xinyang Yu; Shuohua Chen; Shouling Wu; Ni Li; Min Dai; Jie He
Journal:  Cancer Med       Date:  2019-11-26       Impact factor: 4.452

4.  Metabolic Syndrome Components and the Risk of Colorectal Cancer: A Population-Based Prospective Study in Chinese Men.

Authors:  Xin Li; Hongda Chen; Gang Wang; Xiaoshuang Feng; Zhangyan Lyu; Luopei Wei; Yan Wen; Shuohua Chen; Shouling Wu; Dong Hang; Min Dai; Ni Li; Jie He
Journal:  Front Oncol       Date:  2019-10-17       Impact factor: 6.244

5.  Metabolic syndrome and the incidence of lung cancer: a meta-analysis of cohort studies.

Authors:  Li Qiao; Deliang Ma; Hui Lv; Ding Shi; Min Fei; Yu Chen; Fei Xie; Zhuoyan Wang; Ying Wang; Wanhua Liang; Peiying Hu
Journal:  Diabetol Metab Syndr       Date:  2020-10-28       Impact factor: 3.320

6.  [Correlation between Pretreatment Serum Apolipoprotein Level and Prognosis of Small Cell Lung Cancer Patients].

Authors:  Ya Dong; Haocheng Wang; Dongfeng Shan; Linwei Zhang; Zhuang Yu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-10-20

7.  Habitual consumption of alcohol with meals and lung cancer: a Mendelian randomization study.

Authors:  Chongxiang Chen; Qiaozhen Hu; Jiaojiao Wang; Tianmeng Wen; Chaoyang Zhu; Weiyan Tan; Xuelin Chen; Qingyu Zhao; Wei Wang; Huijiao Cao; Huan Li
Journal:  Ann Transl Med       Date:  2021-02

8.  Serum Metabolite Profiles in Participants of Lung Cancer Screening Study; Comparison of Two Independent Cohorts.

Authors:  Piotr Widłak; Karol Jelonek; Agata Kurczyk; Joanna Żyła; Magdalena Sitkiewicz; Edoardo Bottoni; Giulia Veronesi; Joanna Polańska; Witold Rzyman
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

Review 9.  [Research Progress on the Relationship between Blood Lipids and 
Lung Cancer Risk and Prognosis].

Authors:  Ya Dong; Haocheng Wang; Dongfeng Shan; Zhuang Yu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-08-10

10.  Association between pre-diagnostic serum albumin and cancer risk: Results from a prospective population-based study.

Authors:  Zhuoyu Yang; Yadi Zheng; Zheng Wu; Yan Wen; Gang Wang; Shuohua Chen; Fengwei Tan; Jiang Li; Shouling Wu; Min Dai; Ni Li; Jie He
Journal:  Cancer Med       Date:  2021-05-26       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.